Browse by all authors Browse By Author ID - Croker, Daniel

Browse Results (13 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

Refine

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Halai, Reena, Croker, Daniel E., Suen, Jacky Y., Fairlie, David P. and Cooper, Matthew A. (2012) A comparative study of impedance versus optical label-free systems relative to labelled assays in a predominantly Gi coupled GPCR (C5aR) signalling. Biosensors, 2 3: 273-290. doi:10.3390/bios2030273 87   Cited 4 times in Scopus4 0
Sharpe, I. A., Thomas, L., Loughnan, M., Motin, L., Palant, E., Croker, D. E., Alewood, D., Chen, S., Graham, R. M., Alewood, P. F., Adams, D. J. and Lewis, R. J. (2003) Allosteric α1 adrenoceptor antagonism by the conopeptide ρ-TIA. Journal of Biological Chemistry, 278 36: 34451-34457. doi:10.1074/jbc.M305410200 106   34 Cited 38 times in Scopus38 0
Coll, Rebecca C., Robertson, Avril A. B., Chae, Jae Jin, Higgins, Sarah C., Muñoz-Planillo, Raúl, Inserra, Marco C., Vetter, Irina, Dungan, Lara S., Monks, Brian G., Stütz, Andrea, Croker, Daniel E., Butler, Mark S., Haneklaus, Moritz, Sutton, Caroline E., Núñez, Gabriel, Latz, Eicke, Kästner, Daniel L., Mills, Kingston H. G., Masters, Seth L., Schroder, Kate, Cooper, Matthew A. and O'Neill, Luke A. J. (2015) A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nature Medicine, 21 3: 248-257. doi:10.1038/nm.3806 42   1 Cited 4 times in Scopus4 193
Croker, Daniel E., Halai, Reena, Kaeslin, Geraldine, Wende, Elisabeth, Fehlhaber, Beate, Klos, Andreas, Monk, Peter N. and Cooper, Matthew A. (2014) C5a2 can modulate ERK1/2 signaling in macrophages via heteromer formation with C5a1 and beta-arrestin recruitment. Immunology and Cell Biology, 92 7: 631-639. doi:10.1038/icb.2014.32 20   1 Cited 1 times in Scopus1 1
Croker, Daniel E., Halai, Reena, Fairlie, David P. and Cooper, Matthew A. (2013) C5a, but not C5a-des Arg, induces upregulation of heteromer formation between complement C5a receptors C5aR and C5L2. Immunology and Cell Biology, 91 10: 625-633. doi:10.1038/icb.2013.48 38   4 Cited 5 times in Scopus5 0
Dutertre, Sébastien, Croker, Daniel, Daly, Norelle L., Andersson, Åsa, Muttenthaler, Markus, Lumsden, Natalie G., Craik, David J., Alewood, Paul F., Guillon, Gilles and Lewis, Richard J. (2008) Conopressin-T from Conus tulipa reveals an antagonist switch in vasopressin-like peptide. Journal of Biological Chemistry, 283 11: 7100-7108. doi:10.1074/jbc.M706477200 94   30 Cited 33 times in Scopus33 0
Halai, Reena, Bellows-Peterson, Meghan L., Branchett, Will, Smadbeck, James, Kieslich, Chris A., Croker, Daniel E., Cooper, Matthew A., Morikis, Dimitrios, Woodruff, Trent M., Floudas, Christodoulos A. and Monk, Peter N. (2014) Derivation of ligands for the complement C3a receptor from the C-terminus of C5a. European Journal of Pharmacology, 745 176-181. doi:10.1016/j.ejphar.2014.10.041 16   1 Cited 1 times in Scopus1 1
Croker, Daniel, Dutertre, Sebastien, Alewood, Paul and Lewis, Richard (2006). Discovery and pharmacology of conopressin-T, a novel vasopressin-like peptide from Conus tulipa.. In: Acta Pharmacologica Sinica. , , (351-351). . 8   0
Croker, Daniel E., Halai, Reena, Kaeslin, Geraldine, Morikis, Dimitrios, Woodruff, Trent, Floudas, Christodoulos A., Monk, Peter N. and Cooper, Matthew A. (2014). Discovery of novel selective C5a2 ligands that can modulate IL-6 releAse from macrophages. In: 2nd Annual Meeting of the International-Cytokine-and-Interferon-Society (ICIS), Melbourne Australia, (35-35). Oct 26-29, 2014. doi:10.1016/j.cyto.2014.07.039 28   0 0
Croker, Daniel E., Halai, Reena, Fairlie, David P. and Cooper, Matthew A. (2012). Ligand-induced dimerisation of the complement C5aR and C5L2 receptors by C5a but not C5a-des Arg. In: Immunobiology. XXIV International Complement Workshop (ICW), Crete, Greece, (1181-1182). 10-15 October 2012. doi:10.1016/j.imbio.2012.08.152 46   1 0
Croker, Daniel E. (2014). Mapping the signalling pathways and interactions for the complement C5a receptors using novel methodologies PhD Thesis, Institute for Molecular Bioscience, The University of Queensland. doi:10.14264/uql.2014.200 55 6 0
Coll, Rebecca C., Robertson, Avril A. B., Chae, Jae Jin, Higgins, Sarah C., Dungan, Lara S., Munoz-Planillo, Raul, Monks, Brian G., Croker, Daniel E., Sutton, Caroline E., Stutz, Andrea, Nunez, Gabriel, Latz, Eicke, Kastner, Daniel L., Mills, Kingston H. G., Masters, Seth L., Schroder, Kate, Cooper, Matt A. and O'Neill, Luke A. J. (2014). MCC950 is a potent and specific inhibitor of the NLRP3 inflammasome and a novel potential therapeutic for NLRP3 driven diseases. In: 2nd Annual Meeting of the International-Cytokine-and-Interferon-Society (ICIS), Melbourne Australia, (35-35). Oct 26-29, 2014. doi:10.1016/j.cyto.2014.07.037 410   0 12
Brust, Andreas, Palant, Elka, Croker, Daniel E., Colless, Barbara, Drinkwater, Roger, Patterson, Brad, Schroeder, Christina I., Wilson, David, Nielsen, Carsten K., Smith, Maree T., Alewood, Danne, Alewood, Paul F and Lewis, Richard J. (2009) X-conopeptide pharmacophore development: Toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain. Journal of Medicinal Chemistry, 52 22: 6991-7002. doi:10.1021/jm9003413 188   32 Cited 33 times in Scopus33 0